Become A Research Partner

National Brain Tumor Society funds only the most promising research poised to deliver results. Our funded research has contributed to the establishment of many of what are now the top adult and pediatric brain tumor research labs across the country, as well as advances in understanding brain tumor makeup and what could drive more effective treatments.

By partnering with us and supporting our strategic initiatives, you can help advance the understanding of brain tumors, improve the availability of new treatments, and drive the discovery of a cure. Learn more about the initiatives that you can contribute to directly.

Defeat GBM

Glioblastoma multiforme (GBM) is a highly aggressive, complex, and devastating form of brain cancer, effecting hundreds of people each day. We believe it is our duty to accelerate progress against this disease so we launched the Defeat GBM Research Collaborative in 2013 with the intent to double the 5 year survival rate of GBM patients. This comes at a time when collaboration is becoming the norm and the abundance of genomic data is accelerating diagnostic, prognostic, and therapeutic progress.

Oligo Research Fund

Oligodendroglioma (oligo) is a relatively rare brain tumor representing about 6% of gliomas, with a diagnosis rate of about 1,150 patients a year in the U.S. alone. Critical research is required to deliver oligo patients new therapies that are more durable and extend their lives. In order to make effective, targeted therapies a reality it is essential to identify and understand the molecular drivers of the tumor’s genesis and maintenance, as well as resistance.

Defeat Pediatric Brain Tumors Research Collaborative

The Defeat Pediatric Brain Tumors Research Collaborative is a powerful, unique global research and drug discovery program which aims to improve clinical outcomes for pediatric brain tumor patients – and ultimately find a cure for brain tumors to save these kids.

Community Research

The Community Research Fund allows contributors to pool donations to support research on a specific type of tumor. This program leverages a team of highly experienced, nationally-recognized scientific experts, working with National Brain Tumor Society staff, to determine the best investment strategy for each fund.


From the Blog

  • November 4, 2021

    Years of scientific progress lead to hope for glioblastoma patient

    With funding from the National Brain Tumor Society, Clark C. Chen, MD, PhD of the University of Minnesota is ready to start a clinical trial for a drug that is already showing early promise for a glio

    Read More

  • October 8, 2021

    Advocacy in Action: Updates on the Childhood Cancer STAR Act and Childhood Cancer Data Initiative

    The Childhood Cancer STAR Act and Childhood Cancer Data Initiative (CCDI) are major federal government-led initiatives that exist in part because of years of advocacy work by members of the brain tumor and childhood cancer

    Read More

  • October 5, 2021

    NBTS Brain Tumor Clinical Trials Report: Q3 2021

    It can be hard to keep track of new brain tumor clinical trial opportunities opening across the United States, especially as we continue to navigate the public health crisis created by the coronavirus (COVID-19). There

    Read More

More from the blog